Tag: Prescription Drugs
Tirzepatide Improves 24-Hour BP in Obesity-Related Hypertension
Reduction noted in 24-hour systolic BP at 36 weeks with treatment at 5, 10, 15 mg tirzepatide versus placebo
Price of Prescription Drugs Almost Threefold Higher in the United States
U.S. prices for brand-name originator drugs 422 percent higher; price of unbranded generics 67 percent of comparison countries
Treatment With N-Acetyl-L-Leucine Beneficial for Niemann-Pick Disease
Greater mean change from baseline seen in total score on the Scale for the Assessment and Rating of Ataxia with NALL versus placebo
Pembrolizumab Shows Survival Benefit for Patients With Renal Cancer
Significant improvement seen in overall survival with pembrolizumab versus placebo and across key subgroups
Efficacy of Electronic Cigarettes Noninferior to Varenicline
Quit rate higher for ECs than nicotine replacement therapy; at six months, 62.8 percent in EC arm still using ECs
Mislabeled Bottles Trigger Recall of the ADHD Drug Zenzedi
No serious injuries related to the medication mix-up have been reported
Strategies Needed to Improve Delivery of Alzheimer Disease-Modifying Therapies
Models that enable primary care practitioners to diagnose and evaluate patients for treatment eligibility would have biggest impact on wait times
GLP1 Agonists Reduce Major Adverse Liver Outcomes in Chronic Liver Disease
For patients with chronic liver disease and type 2 diabetes, GLP1 agonist initiators associated with lower risk for major adverse liver outcomes
Addition of Durvalumab, Bevacizumab to TACE Beneficial in Liver Cancer
Progression-free survival significantly improved in unresectable hepatocellular carcinoma versus TACE alone
Dexmedetomidine Cuts Incidence of Postpartum Depression After C-Section
Reduction in incidence of positive PPD screening seen among women with prenatal depression undergoing elective C-section
